Carisma jumps as drug discovery under Moderna deal leads to $2M payment [Seeking Alpha]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Seeking Alpha
Nominating the first development candidate under the partnership, the company said that the unnamed drug targets Glypican-3, a cancer antigen highly expressed in hepatocellular carcinoma, the most common form of liver cancer. The Philadelphia, Pennsylvania-based company added that the $2M it is entitled to receive will be a milestone payment that Moderna ( MRNA ) agreed to pay when the duo joined hands in 2022 to develop chimeric antigen receptor monocyte (CAR-M) cancer therapies. “This milestone represents a significant step forward in the development of immunotherapies for solid tumors and an advance for the in vivo cell therapy field,” said Carisma's ( CARM science chief, Michael Klichinsky. Recommended For You More Trending News Recommended For You More Trending News Related Stocks In The News Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- U.S. awards Moderna $176 million to produce bird flu vaccine [CNBC]CNBC
- Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine [Yahoo! Finance]Yahoo! Finance
- Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza VaccineAccesswire
- US Inks Vaccine Deal With Moderna as Bird Flu Threat Looms [BNN Bloomberg (Canada)]BNN Bloomberg
- Building capacity for new modalities: Inside Cytiva's first end-to-end cGMP facility for mRNA manufacturing [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 5/2/24 - Beat
MRNA
Sec Filings
- 6/28/24 - Form 4
- 6/26/24 - Form 144
- 6/21/24 - Form 4
- MRNA's page on the SEC website